This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...

Doctors have an overwhelming amount of individual patient data and medical research at their disposal to make diagnoses and ...

Eli Lilly is partnering with the fabled venture capital firm Andreessen Horowitz on a new fund backed with $500 million of ...

Preparing cancer patients for difficult decisions is an oncologist's job. They don't always remember to do it, however.

Bagsværd, Denmark Friday, January 10, 2025, 11:00 Hrs [IST] ...

A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...

Leading private capital deals today include Blackstone's $300 million investment in DDN and a B Capital-led $275 million ...

Hippocratic AI, a startup building AI solutions that can handle non-diagnostic patient-facing tasks, secured a massive $141 ...

Nearly 30% of the funding poured into healthcare startups last year, including for biotechs, went to companies leveraging ...

AI can compare thousands of images to uncover dangerous patterns, create ultra-high resolution scans from low-res images and ...

Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...

In November 2023, the estates of two now-deceased policyholders sued the US health insurer, United Healthcare, for deploying ...